Description
Mouse CD90.2+ cells are either selected or depleted by incubating the sample with biotin conjugated anti-mouse CD90.2 antibody followed by streptavidin magnetic nanoNanoparticles. The magnetically labeled antibody is pulled out by the use of a magnetic separator. After collection of the CD90.2+ expressing cells, downstream applications include functional assays, gene expression, phenotypic characterization, etc. These magnetic nanoparticles can be used wiht both free standing magnets and column-based systems